- ByInvesting.com-
Investing.com -- Morgan Stanley outlined two stocks as its top picks in the European chemicals sector, highlighting their...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 245.60 | 246.40 | 244.40 | +1.20 | +0.49% | 26.4K | ||
| 89.15 | 89.45 | 87.00 | +1.65 | +1.89% | 53.67K | ||
| 118.30 | 119.55 | 117.60 | -0.70 | -0.59% | 334.85K | ||
| 25.38 | 25.54 | 25.06 | -0.46 | -1.78% | 483.26K | ||
| 79.50 | 79.50 | 78.90 | +0.45 | +0.57% | 58.38K | ||
| 253.30 | 260.00 | 250.10 | -8.70 | -3.32% | 170.51K | ||
| 58.72 | 59.18 | 58.00 | -0.10 | -0.17% | 1.57M | ||
| 59.55 | 59.55 | 58.40 | +1.20 | +2.06% | 234.15K | ||
| 21.28 | 22.08 | 21.20 | -0.08 | -0.37% | 593.67K | ||
| 75.55 | 75.75 | 73.45 | +1.85 | +2.51% | 121.89K | ||
| 122.30 | 122.50 | 119.50 | +1.80 | +1.49% | 156.4K | ||
| 9,900.0 | 9,950.0 | 9,650.0 | +240.0 | +2.48% | 1.61K | ||
| 64.75 | 66.60 | 64.10 | +1.05 | +1.65% | 48.13K | ||
| 71.70 | 71.80 | 70.40 | +0.50 | +0.70% | 36.12K | ||
| 245.80 | 245.80 | 243.60 | -0.20 | -0.08% | 19.42K | ||
| 23.30 | 23.42 | 22.96 | +0.32 | +1.39% | 406.91K | ||
| 196.00 | 196.00 | 192.40 | +4.50 | +2.35% | 106.04K | ||
| 710.20 | 722.60 | 707.20 | -22.00 | -3.00% | 112.87K | ||
| 8.33 | 8.33 | 7.93 | +0.31 | +3.87% | 468.14K | ||
| 72.26 | 72.50 | 70.72 | +0.98 | +1.37% | 87.06K |
Investing.com -- Morgan Stanley outlined two stocks as its top picks in the European chemicals sector, highlighting their...
Investing.com -- Jefferies on Friday has initiated equity research coverage on Elia Group SA/NV, a European electricity...
Investing.com -- Belgian healthcare real estate company Aedifica has received regulatory approval for its acquisition of...
Upcoming U.S. retail sales data is expected to influence market perceptions, building on a recent increase. Companies like Target...
After the Iran-Israel situation fizzled out for the time being, the Cboe Volatility Index (VIX) dropped from its yearly high of...
Dividend stocks can provide regular income and outperform the broader market. When building a dividend portfolio, investors should...
No Earning Reports have been scheduled